PRTC
PureTech Health plc
NASDAQ · Healthcare · Biotechnology · US
$17.38
+2.12%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 9.0M | 4.7M | 4.8M | 3.3M | 2.1M |
| Cost of Revenue | 26.5M | — | 3.6M | 4.9M | 152.4M |
| Gross Profit | (17.6M) | 4.7M | 1.3M | (1.6M) | (136.8M) |
| Operating Expenses | |||||
| R&D Expense | 110.7M | 45.7M | 54.3M | 96.2M | 116.1M |
| SG&A Expense | 72.4M | 20.7M | 27.5M | 48.4M | 35.7M |
| General & Admin Expense | 52.4M | 20.7M | 27.5M | 25.2M | 35.7M |
| Selling & Marketing Expense | — | — | — | 23.2M | — |
| Other Expenses | 33.7M | 36.8M | 58.6M | (90.0M) | (90.8M) |
| Total Operating Expenses | 216.8M | 103.2M | 140.4M | 54.6M | 61.0M |
| Cost and Expenses | 243.4M | 103.2M | 140.4M | 149.5M | 213.4M |
| Operating Income (EBIT) | (234.4M) | (98.5M) | (136.1M) | (146.2M) | (197.8M) |
| Non-Operating | |||||
| Interest Income | 35.8M | 13.0M | 22.7M | 16.0M | 5.8M |
| Interest Expense | 55.7M | 45.8M | 10.0M | 13.5M | 4.0M |
| Net Interest Income | (19.9M) | (32.7M) | 12.6M | 2.5M | 1.8M |
| Other Non-Op Income/Expense | 147.5M | (12.4M) | 159.9M | 110.1M | 105.0M |
| Non-Operating Income (excl Interest) | (169.9M) | (33.4M) | (169.9M) | (129.6M) | (1.0K) |
| EBT (Pre-Tax Income) | (86.9M) | (110.9M) | 23.8M | (36.1M) | (92.8M) |
| Income Tax Expense | (4.8M) | (842.0K) | (4.0M) | 30.5M | (55.7M) |
| Bottom Line | |||||
| Net Income | (56.0M) | (109.7M) | 53.5M | (65.7M) | (50.4M) |
| Earnings from Cont. Ops | (82.1M) | (110.1M) | 27.8M | (66.6M) | (37.1M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (56.0M) | (109.7M) | 53.5M | (65.7M) | (50.4M) |
| Per Share | |||||
| Basic EPS | ($26.80) | ($46.00) | $2.00 | ($2.40) | ($1.80) |
| Diluted EPS | ($26.80) | ($46.00) | $2.00 | ($2.40) | ($1.80) |
| Revenue Per Share | $3.71 | $1.93 | $0.18 | $0.12 | $0.07 |
| Shares | |||||
| Basic Shares Outstanding | 2.4M | 2.4M | 27.0M | 27.6M | 28.0M |
| Diluted Shares Outstanding | 2.4M | 2.4M | 27.0M | 27.6M | 28.5M |
| Profitability Metrics | |||||
| EBITDA | (57.6M) | (61.8M) | 37.4M | (11.6M) | (188.9M) |
| D&A | 6.9M | 3.3M | 3.6M | 4.9M | 8.9M |
| EBIT | (64.5M) | (65.2M) | 33.8M | (16.6M) | (197.8M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025